Journal ArticleOPEN ACCESS

Ryeqo for the treatment of the symptoms of uterine fibroids

  • Chaplin S
Prescriber (2023) 34(1) 31-32
DOI: 10.1002/psb.2036
N/ACitations
Citations of this article
6Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Ryeqo is a combined formulation of relugolix, estradiol and norethisterone for the treatment of moderate to severe symptoms of uterine fibroids. This article outlines its efficacy, adverse effects and place in therapy.

Cite

CITATION STYLE

APA

Chaplin, S. (2023). Ryeqo for the treatment of the symptoms of uterine fibroids. Prescriber, 34(1), 31–32. https://doi.org/10.1002/psb.2036

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free